学术投稿
国际转化医学(英文版)杂志

国际转化医学(英文版)杂志

(非官网)

  • 主管单位:医学第三方国际出版集团有限公司
  • 主办单位:医学第三方国际出版集团有限公司
  • 国际刊号:2227-6394
  • 国内刊号:
  • 影响因子:
  • 创刊:2003
  • 周期:
  • 发行:
  • 语言:中文
  • 邮发:
  • 全年订价:0.00
期刊收录 期刊荣誉 期刊标签
  • Ulrich的期刊目录(UPD)
  • 医药卫生综合
  • 还需要咨询该刊物的详情?->
相关期刊
最新资讯
期刊级别:
产品参数:
主管单位:医学第三方国际出版集团有限公司
主办单位:医学第三方国际出版集团有限公司
出版地方:
期刊标签:医药卫生综合
国际刊号:2227-6394
国内刊号:
邮发代号:
创刊时间:2003
发行周期:

国际转化医学(英文版)杂志简介

     《国际翻译医学杂志》(JITM, ISSN 2227-6394)创办于2012年,是由国际翻译医学基金会主办,国际翻译医学杂志有限公司出版的英文学术期刊。JITM是一个开放存取的免费期刊,提供提交、审查、出版、阅读和下载全文和引用。JITM是一本季刊,第一期于2013年3月出版,所有英文文章均由专业平面设计师按照国际编辑标准进行编辑编辑。JITM编辑委员会的所有成员都是来自美国、英国、法国、德国等20个不同国家和地区的翻译医学领域的著名国际专家。

栏目设置

杂志收录/荣誉

/ Ulrich的期刊目录(UPD)

国际转化医学(英文版)杂志投稿要求

国际转化医学(英文版)杂志社征稿要求

  所有稿件均应按照“ 提交给生物医学期刊的手稿的统一要求:生物医学出版物的书写和编辑 ” 编写。对于随机对照试验,必须说明伦理委员会批准并签署每个受试者的知情同意书。所有稿件均应使用计算机软件以标准语法英语书写,按以下顺序排列并保存为单个DOC(Word)文件。

  1.标题页

  2.摘要和关键词

  3.正文

  4.致谢,如果有的话

  5.参考文献

  6.表格,如果有的话

  7.图,如果有的话

  标题页

  标题页应包括:

  1。简洁的标题,但内容丰富; 相应作者的电子邮件地址。

  2.每个作者的名字,中间名和姓氏,部门名称和每位作者的机构隶属关系,用作跑头的简称,以及

  摘要和关键词

  摘要不应超过400字,简明扼要地总结研究的目的,重要发现和结论。在摘要的最后包含最多8个关键词或短语。

  主要文字

  正文应包括导言,材料和方法,结果和讨论。引言应该简明扼要,明确说明研究的目的和理由。在材料和方法中,应充分详细地描述程序,以允许独立观察者进行复制。结果和讨论可以组合或分开。它们应该简明扼要地写成,并强调新颖的发现。

  致谢

  所有确认(如果有的话)都应包括在参考文献之前的正文末尾,并可能包括赠款和行政支持。

  参考

  在JITM中发表的参考文献应按照文中引用的顺序编号,包括表格和图中的引用。需要完整的作者引用(可以使用“等”)。参考文献应符合期刊的风格。示例如下:

  期刊: 1 Thompson RH,Zang X,Lohse CM,et al。血清可溶性B7x在肾细胞癌患者中升高并且与晚期相关。Cancer Res,2008,68:6054-8。

  书章: Cheng L,Lopez-Beltran A,MacLennan GT,et al。膀胱肿瘤。在:Bostwick DG,Cheng L,编辑。泌尿外科病理学。第2版。费城:Elsevier / Mosby,2008:259-352。

  网站:请参阅下面的“数据补充”部分,以正确使用网站参考。只引用文字。

  印刷中:仅用于接受出版的论文。引用期刊(印刷中)代替卷和页码。

  提交的论文/未发表的数据:添加了DIO。

  表

  必须使用(表1,表2等)创建所有表格,并且应在主文本中连续引用阿拉伯数字。每个表必须在表的顶部有一个描述性标题。在表格的脚注中提供对任何非标准缩写的解释。

  数据

  所有数字应在正文中连续引用阿拉伯数字(图1,图2等)。所有数字必须以TIFF或JPEG格式提交,作为标有相应数字的单独文件。

  出版费

  JITM是一个开放获取期刊,可以即时,全球和无障碍地访问所有已发表文章的全文。出版物免费,编辑委员会将在出版后免费为每位作者发送期刊。

杂志分析报告

名词解释:

影响因子:指该期刊近两年文献的平均被引用率,即该期刊前两年论文在评价当年每篇论文被引用的平均次数

被引半衰期:衡量期刊老化速度快慢的一种指标,指某一期刊论文在某年被引用的全部次数中,较新的一半被引论文刊载的时间跨度

期刊发文量:通常是指在特定时间内,一个学术期刊所发表的论文数量。计算期刊发文量是评估期刊生产力和影响力的一个重要指标,也是学者选择投稿期刊时常常考虑的因素之一。

期刊他引率:期刊被他刊引用的次数占该刊总被引次数的比例用以测度某期刊学术交流的广度、专业面的宽窄以及学科的交叉程度

总被引频次:指该期刊自创刊以来所登载的全部论文在统计当年被引用的总次数。这是一个非常客观实际的评价指标,可以显示该期刊被使用和受重视的程度,以及在科学交流中的作用和地位。

平均引文率:在给定的时间内,期刊篇均参考文献量,用以测度期刊的平均引文水平,考察期刊吸收信息的能力以及科学交流程度的高低

国际转化医学(英文版)杂志影响因子
国际转化医学(英文版)杂志发文量
国际转化医学(英文版)杂志总被引频次

杂志文章摘录

  • Objective:To explore the effect of ibandronate on the proliferation and the expression of human telomerase reverse transcriptase (hTERT) of non-small cell lung cancer (NSCLC) A549 cell line in vitro. Methods: Methyl thiazolyl tetrazolium (MTT) assay, microscope, flow cytometry (FCM) and semi-quantitative RT-PCR were employed to detect the cell proliferation, cell cycle as well as the morphological change and the expression of hTERT mRNA of A549 cell line. Results:The data showed that ibandronate could effectively inhibit the proliferation of A549 cell line in time-and concentration-dependent. Under the microscope, the lfoating cells increased gradually as the drug concentration increasing. FCM detection showed that ibandronate could induce the cell cycle stopped in G0/G1 phase and downregulation expression of hTERT. Conclusion:Ibandronate can inhibit the proliferation of A549 cell line in vitro, whose mechanism may be associated with cell cycle arrestted in phase G0/G1 and downregulation expression of hTERT.

    作者: 刊期: 2014年第03期

  • Objective:To comprehend the characteristics of patients with positive human immunodeifciency virus (HIV) (1+2) antibodies in the preliminary screening so as to provide basis for local HIV screening and prevention. Methods:Enzyme-linked immunosorbent assay (ELISA) was used to detect serum HIV (1 +2) antibodies in the preliminary screening, after which the positive serum was sent to acquired immune deficiency syndrome (AIDS) confirmatory laboratory to be confirmed with western blotting method. Clinical data of patients with positive HIV antibodies in the preliminary screening in the outpatients and inpatients from 2006 to 2013 were collected and analyzed. Results:A total of 394 patients with positive serum HIV antibodies were screened initially, in which 214 were confirmed positive HIV, 13 were not certain and another 167 were negative. Patients with positive serum HIV antibodies in the preliminary screening were increased from 9 cases in 2006 to 94 cases in 2013, in which those conifrmed with positive HIV increased from 5 to 49. Patients with positive serum HIV antibodies in the preliminary screening and those conifrmed increased annually. In addition, patients confirmed with positive serum HIV antibodies were mainly males and aged 20 ~ 49 years, distributing in Departments of Infections, Respiratory, Dermatology, Hematology and Emergency, whereas those confirmed with negative HIV were mainly females and aged >20 years, distributing in Departments of Hematology, Maternity and Emergency as well as Reproductive Center. Conclusion: HIV infection is in low level with characteristics of annually increasing infection rate, male-orientated and wide-spread distribution in variuos departments, etc., knowing which will help guide the clinical practices and carry out the local HIV screening and prevention by relevant departments.

    作者: 刊期: 2014年第03期

  • As a new branch of medicine with unlimited prospect, Translational Medicine has been rapidly developed over the past decades and gained global attention. Translational Medicine can be vividly described as“bench to bedside (B2B)”model which focuses on the integration of multiple aspects, especially the basic medicine and clinical medicine, and has a great potential in treating many severe diseases and improving human health. Medical journals are carriers for medical information and play a great role in the development of medicines, and Journal of International Translational Medicine (JITM) is just a journal emerging at the right moment and specialized in translational medicine. With professionalized attitude and internationalized requirements, JITM is committed to promote the development of Translational Medicine.

    作者: 刊期: 2014年第03期

  • A case of a 53-year-old man with adult T-lymphoblastic lymphoma (T-LBL) in mediastinum who survived more than 33 months in our hospital was reported. LBL was more common in school-age and teenage boys than adults. The reported patient manifested progressive dyspnea. Chest CT scanning showed a huge irregular soft tissue shadow in anterior mediastinum which extended into posterior mediastinum and left chest wall. The tumor was 20 cm×15 cm×15 cm in size in left upper mediastinum and its boundaries with pericardium and left lower lung were unclear. The diagnosis of T-lymphoblastic lymphoma was confirmed by immunohistochemical staining. After surgery, he received five chemotherapy courses including Gem, CTX and VCR and biological therapies with IL-2 and IFN-α2b. About 16 months later, he complained of diplopia in the left eye without any evidence of recurrence. Blood examination which showed leukemoid reaction twice returned to normal after dehydration, hormone and thalidomide treatments. Finally, his condition became worse and died of pulmonary infection 33 months after ifrst medical service. In summary, T-LBL is a rare disease which may result in poor prognosis even if the patient has received immediate chemotherapy. Hormone and thalidomide can be applied to treat adult T-LBL.

    作者: 刊期: 2013年第02期

  • Objective:To explore the proliferation inhibition and apoptosis-inducing effect of evodiamine in human gastric cancer SGC-7901 cells. Methods:After 48 or 24 h exposure to different concentrations of evodiamine, cell proliferation was analyzed using tetrazolium blue (MTT) assay while apoptosis and cell-cycle phase distribution using lfow cytometry. Results:In 0.01~30.00μg/mL range of concentrations, evodiamine inhibited the proliferation of SGC-7901 cells in dose-dependent manner, and the overall mean IC50 was (3.79±0.16)μg/mL;the apoptosis rate was increased from 3.4%to 7.0%, 13.8%and 36.3%at concentrations of 0, 0.5, 1.5 and 30μg/mL of evodiamine, respectively;the percentage of cells accumulated in G2/M phase was increased from 17.26%to 98.92%in the cells treated with evodiamine for 24 h in 0.01~30.00μg/mL range of concentrations. Conclusion:Evodiamine can inhibit the proliferation, induce apoptosis in human gastric cancer cell line SGC-7901 in vitro and arrest the cell cycle at the G2/M phase.

    作者: 刊期: 2014年第03期

  • Objective:To investigate the clinical value of total knee arthroplasty (TKA) on patients with advanced knee osteoarthritis. Methods:The clinical data and efficacy of 26 patients with advanced knee osteoarthritis (26 knees) who were given TKA in our department from June 2012 to May 2013 were retrospectively observed and analyzed. The knee function scores before operation and after follow up were evaluated according to American HSS scoring standard. Results:At the end of follow up, of the 26 patients, 18 were excellent, 6 were good and 2 were not bad in knee function and mobility without sense of pain, which was regarded to be associated with the poor enthusiasm in knee function training, and the total rate of excellent and good was 92.3%. Conclusion:TKA has signiifcant clinical value and favorable efifcacy on patients with advanced knee osteoarthritis.

    作者: 刊期: 2014年第03期

  • Ebola virus disease (EVD) is an acute hemorrhagic infectious disease caused by ebola virus, with high infectivity and fatality rate. At present, it mainly occurs in areas of Central Africa and West Africa and no effective vaccine and antiviral drugs are available for the clinical treatment.

    作者: 刊期: 2014年第03期

  • 作者: 刊期: 2013年第02期

  • Objective:To observe the expressions of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer. Methods:Neoplastic tissues and autologous non-neoplastic tissues were taken from 12 patients with colorectal cancer immediately after the operations. The mRNA expressions of 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) and 11beta-hydroxysteroid dehydrogenase type 2 (11β-HSD2) were detected by reverse transcription polymerase chain reaction (RT-PCR). The protein expressions of 11β-HSD1 and 11β-HSD2 were detected by Western-blot assay. Results:Both isoforms of 11β-HSD expressed in the colon adenocarcinoma, but their expressions were not identical in neoplastic and non-neoplastic tissues. There was a significant decrease of 11β-HSD2 mRNA abundance and protein abundance in neoplastic tissue. 11β-HSD1 protein and mRNA abundance were not signiifcantly different from that in control tissue. Conclusions:Neoplastic transformation is associated with the decreases of 11β-HSD2 mRNA and protein.

    作者: 刊期: 2014年第03期

  • Cancer is always a main factor threatening human’s health and life, and its incidence and mortality are gradually increasing in recent years. However, some advances have been made with the unremitting efforts and exploration human made and the improvement is mainly made in cancer treatment of young children and older adults, while little in adolescent and young adult (AYA) patients, who are generally defined as individuals of 15 to 39 years old at the time of initial cancer diagnosis due to many factors. To highlight the issues of this unique population, National Comprehensive Cancer Network (NCCN) absorbs a large amount of information and previous researches and develops a set of clinical practice guidelines. Though the guidelines are more supportive care guidelines than treatment guidelines, they give us the opportunity to learn the latest international developments in AYA treatment and more survival chance for the treatment of AYA patients.

    作者: 刊期: 2014年第03期

杂志往期目录

更多评论>>

网友反馈(不代表本站观点)

明哥** 的反馈:

等得好心急哟,编辑大哥大姐们,能不能快点审下我的稿子

罗羽明** 的反馈:

急急,国际转化医学(英文版)杂志 投稿要多长时间才能出结果,投了好久了,没见一点动静,有人告诉我么

王德平** 的反馈:

请问这个刊物需要英文摘要吗?知道的可以告诉我吗?

谢正勇** 的反馈:

请问一下,国际转化医学(英文版)杂志 投稿授权证明要不要盖单位的章,录用了,说要搞个什么授权证明。

nblove** 的反馈:

9月中旬在投国际转化医学(英文版)杂志的稿,10月就通知录用啦,速度杠杠的。需要说的是,这本杂志的编辑排版很严格,录用后会有多次排版校对,编排质量很高,编辑工作非常严谨认真,值得赞扬!

姓名保密** 的反馈:

审稿速度很快,我是2月10日投的稿件,一个月不到就返回了审稿意见,速度上还是很认可的,编辑老师很认真负责,专家也很专业,给出的意见都很可观,让我受益很多。

flytoyou** 的反馈:

退得挺快,挺好的[流泪]

小鲸** 的反馈:

国际转化医学(英文版)杂志在同类刊物里面相对比较容易中,审稿有回复,退稿有温度(笔者之前的文章因改动较大,杂志建议退稿之后修改重投),不失为一种选择

快点毕业** 的反馈:

各位学友,这个期刊是不是投稿就会通过初审? 看我很多投稿的朋友说,初审后被拒稿的也很多啊……

康新隆** 的反馈:

投稿一周,就说初审没过,我好想大哭一场,投这个刊物怎么这么难[伤心][难过]